We are live on ! Find out more
SSCM

Summit Street Capital Management Portfolio holdings

AUM $707M
1-Year Est. Return 76.8%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+76.8%
3 Year Est. Return
+144.33%
5 Year Est. Return
+200.14%
10 Year Est. Return
+704.53%
AUM
$274M
AUM Growth
+$13.3M
Cap. Flow
+$15.4M
Cap. Flow %
5.63%
Top 10 Hldgs %
48.52%
Holding
31
New
Increased
20
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$2.64M
2
MOH icon
Molina Healthcare
MOH
+$2.08M
3
CSCO icon
Cisco
CSCO
+$1.99M
4
GNTX icon
Gentex
GNTX
+$1.63M
5
WBD icon
Warner Bros
WBD
+$1.58M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$2.89M
2
GILD icon
Gilead Sciences
GILD
+$1.84M
3
KLAC icon
KLA
KLAC
+$1.32M
4
MED icon
Medifast
MED
+$1.13M
5
AMAT icon
Applied Materials
AMAT
+$1M

Sector Composition

Rank Sector Weight
1 Technology 31.32%
2 Energy 16.99%
3 Healthcare 13.77%
4 Financials 12.97%
5 Materials 12.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
26
Intel
INTC
$492B
$6.23M 2.28%
201,117
GNTX icon
27
Gentex
GNTX
$5.02B
$6M 2.19%
178,028
+47,172
+36% +$1.63M
MGA icon
28
Magna International
MGA
$18.7B
$4.15M 1.52%
99,067
+27,254
+38% +$1.27M
FOXA icon
29
Fox Class A
FOXA
$26.6B
$2.16M 0.79%
62,801
GILD icon
30
Gilead Sciences
GILD
$165B
-25,064
Closed -$1.84M
MED icon
31
Medifast
MED
$135M
-29,500
Closed -$1.13M

Similar funds

Summit Street Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Summit Street Capital Management held 31 positions worth $274M, up 5.1% from $260M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Summit Street Capital Management deployed $15.4M of net new capital in Q2 2024, adding to 20 existing holdings.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Micron Technology, an estimated $2.89M trimmed.

  • Summit Street Capital Management added most to Humana in Q2 2024, an estimated $2.64M increase.
  • Summit Street Capital Management's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $2.89M.
  • Summit Street Capital Management fully exited Gilead Sciences in Q2 2024, selling an estimated $1.84M.
  • Summit Street Capital Management's ten largest holdings make up 49% of its $274M portfolio in Q2 2024.
  • Summit Street Capital Management opened 0 new positions and closed 2 in Q2 2024.
  • Summit Street Capital Management's portfolio value rose 5.1% quarter-over-quarter to $274M.

Based on Summit Street Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.